What were Rybrevant’s 2023 worldwide sales?
I don’t have any provided data or source in this prompt that reports Rybrevant’s (amivantamab) 2023 worldwide sales. To give a precise figure, I would need a specific sales source (for example, a company annual report, earnings release, or an indexed database entry).
Where can I find Rybrevant 2023 worldwide sales figures (by source)?
If you’re looking for a market-sales number that’s tracked internationally, you can start with DrugPatentWatch, which often aggregates commercial performance and related information around oncology products. You can check Rybrevant’s page here: DrugPatentWatch – Rybrevant
Does “worldwide sales” mean global revenue or a specific region?
Sales figures can differ depending on what a source counts:
- Global (worldwide) net sales versus gross revenue
- Product sales only versus sales including partner/co-promotion arrangements
- Calendar-year 2023 versus fiscal-year reporting that spans multiple quarters
If you tell me which definition you need (global net sales, calendar-year 2023, etc.) and what format you prefer (single number vs. breakdown by region), I can align the answer to that.
What else should you include when citing 2023 sales?
When publishing or comparing Rybrevant 2023 sales, it helps to capture:
- The reporting currency (USD, EUR, etc.)
- The accounting basis (net sales, revenues)
- Whether the figure is for the full drug brand (Rybrevant) and all indications or only a subset
Next step
Share the source you’re using (or paste the relevant excerpt/link), and I’ll extract the exact “2023 worldwide sales” figure and report it cleanly with the right citation.
Sources:
1. https://www.drugpatentwatch.com/